WashU study co-author and epidemiologist, Ziyad Al-Aly, MD discusses the “staggeringly high burden” of long COVID in the past two+ years.
Wait goes on for effective long Covid treatments (Links to an external site)

WashU study co-author and epidemiologist, Ziyad Al-Aly, MD discusses the “staggeringly high burden” of long COVID in the past two+ years.
Ziyad Al-Aly, WashU epidemiologist and Institute for Public Health faculty scholar says a new study shows that people can still show symptoms of long COVID even if they originally tested negative.
WashU Public Health Faculty Scholar and Veterans Affairs physician, Ziyad Al-Aly says 2/3 of the current health problems he studied in patients occurred with increased risk two years after their initial hospitalization for COVID-19.
A new study by Institute for Public Health Faculty Scholar & senior author, Ziyad Al-Aly, MD, shows that for some who contracted COVID-19, pain and suffering may continue for two years after infection.
Some new small treatment studies on long COVID symptoms are “a step in the right direction” according to Faculty Scholar and epidemiologist, Ziyad Al-Aly, MD
Institute for Public Health Faculty Scholar Ziyad Al-Aly, MD, is featured in this month’s WashU’s Outlook Magazine about his work on “society’s biggest health issues through vast data analysis”
School of Medicine Clinical Epidemiologist and Faculty Scholar, Ziyad Al-Aly discusses how long COVID can manifest as heart problems.
Senior author, Ziyad Al-Aly. MD has published a study in JAMA Internal Medicine showing that Paxlovid is an “effective weapon” against COVID’s debilitating long-term effects on the body.
Finally some good news about long COVID. Ziyad Al-Aly, director of WashU’s Clinical Epidemiology Center says its complicated, but LC symptoms are less common now.
Chief of research and development at Veteran Affairs St. Louis Health Care System, Ziyad Al-Aly discusses the possibility of getting long COVID
Those who have experienced COVID-19 infection may have issues with gastrointestinal disorders within a year, according to a team study led by Ziyad Al Aly, MD.
Faculty Scholar Ziyad Al-Aly, a clinical epidemiologist led COVID-19 research in 2020 and continues to see how later variants are impacting heart health.
Ziyad Al-Aly, a clinical epidemiologist studying long COVID published two studies which found that COVID-19 creates a greater risk of future cardiovascular diseases.
Epidemiologist and Faculty Scholar, Ziyad Al-Aly led a study showing a higher likelihood of death or hospitalization among COVID-19 patients who have been infected more than once vs. those infected only once.
Faculty Scholar and clinical epidemiologist, Ziyad Al-Aly talks about COVID-19 as a risk factor for heart disease.
Ziyad Al-Aly, faculty scholar and epidemiologist says news of COVID-19 rebounds may be “overblown”.
Ziyad Al Aly, epidemiologist and institute faculty scholar says that after a COVID diagnosis people who haven’t had cholesterol problems before, are now having problems.
Clinical epidemiologist and Faculty Scholar, Ziyad Al-Aly, MD, discusses immunity vs. health risks following COVID reinfection.
Faculty Scholar and clinical epidemiologist, Ziyad Al-Aly, MD, who studies long COVID, discusses mitigation efforts to stop the prolonged impact of the virus.
Clinical epidemiologist and Faculty Scholar, Ziyad Al-Aly has a different opinion of a new, large study finding that long Covid symptoms clear after a year.
Clinical Epidemiologist, Ziyad Al-Aly, MD talks about the “remarkably high” spread of the latest Omicron variant.
Faculty Scholar, Ziyad Al-Aly, epidemiologist, says infection is likely to soar further as millions travel for the Chinese lunar New Year in a few weeks.
Faculty Scholar Ziyad Al-Aly, epidemiologist at WashU’s School of Medicine led a study that detected sharp increases in cardiovascular patients a year after they had COVID-19.
Faculty Scholar Ziyad Al-Aly weighs in on neurological disorders that could come as a result of COVID.
Faculty Scholar and clinical epidemiologist, Ziyad Al-Aly, MD, talks about a Stanford study on the COVID-19 drug, Paxlovid.
Institute for Public Health Faculty Scholar and chief of research at the VA STL Health Care System responds to the question of attending large indoor/outdoor sporting events.
Lead study author Ziyad Al-Aly, MD, assistant professor at the School of Medicine and Faculty Scholar researched whether or not the risk of complications rise the more times you’re infected with COVID.
Assistant Professor of Medicine and Institute Faculty Scholar, Ziyad Al-Aly, MD, authored a new study showing the likelihood that dominant COVID-19 subvariants could mean a harsh winter in terms of illness.
A story by the School of Medicine says that research led by Institute Faculty Scholar, Al-Aly found that repeat SARS-CoV-2 infections contribute significant additional risk of adverse health conditions in multiple organ systems. Photo by Matt Miller.
Faculty Scholar, Ziyad Al-Aly’s latest study shows Paxlovid can reduce long-Covid. His team evaluated veteran’s administration patients at high risk.
Ziyad Al-Aly, MD, epidemiologist and Faculty Scholar, studied people with positive COVID-19 cases and those without for this study.
Faculty Scholar Ziyad Al-Aly talks with NPR about the severity of the flu vs. COVID-19.
Read this Bloomberg article about research conducted by Institute Faculty Scholar and Assistant Professor at the School of Medicine, Ziyad Al-Aly MD, on the long-term effects of COVID-19 infection.
Check out Women’s Health article featuring Institute Faculty Scholar and Associate Professor at the School of Medicine Ziyad Al-Aly’s research on COVID-19 reinfections
Read Desert News article featuring Institute Faculty Scholar and Associate Professor at the School of Medicine Ziyad Al-Aly’s research on COVID-19 reinfections
Read this Los Angeles Times article featuring research conducted by Ziyad Al-Aly, institute faculty scholar and assistant professor at the School of Medicine, on the prevalence of long COVID and the threat of developing additional conditions.
Read this Los Angeles Times article featuring research conducted by Ziyad Al-Aly, institute faculty scholar and assistant professor at the School of Medicine, on the prevalence of long COVID and the threat of developing additional conditions.
Ziyad Al-Aly, institute faculty scholar, discusses the additional risks of repeated COVID-19 reinfections with TIME
Read healthlin article featuring Institute Faculty Scholar and Associate Professor at the School of Medicine Ziyad Al-Aly’s research on COVID-19 reinfections
Check out this NPR story on research conducted by Institute Faculty Scholar, Ziyad Al-Aly on the effect of repeated COVID-19 infections, Al-Aly found that each “reinfection contributes to additional risk”.
Institute Faculty Scholar, Ziyad Al-Aly, speaks with The Washington Post about the additional risks posed by repeated infections of COVID-19
Check out this article, featuring Institute Faculty Scholar, Ziyad Al-Aly, which spotlights a recent finding: each positive COVID-19 case may increase the risk of developing additional issues such as cardiovascular disorders and diabetes.
Ziyad Al-Aly, MD, says that as we uncover more about long Covid, we are starting to see that some consequences will “last a lifetime”.
Ziyad Al-Aly, MD, comments on a study showing that some long Covid symptoms are likely associated with certain variants.
Ziyad Al-Aly, MD, provides more insight into new diabetes diagnosis’ following a COVID infection.
Institute Faculty Scholar, Ziyad Al-Aly, MD says that the mental health risk of COVID-19 and its variants needs more attention.
Read these observations from Ziyad Al-Aly, MD about the reach of long COVID within different areas of the body.
Ziyad Al-Aly, MD, explains that heart disease risk increases significantly after a COVID case regardless of a person’s age, health (no oxford comma needed here) or severity of symptoms.